NYSE · traded in Congress
Johnson & Johnson JNJ
$278.99 +2.77 (+1.00%) Nov 9, 2026 4:29 AM ET
Market value$671.6B
P/E ratio-
Analyst target$280.00
52-week range-
Avg volume6,429,776
Dividend yield-
Chart
Analyst ratings
- 18 buy
- 7 hold
- 2 sell
Low target$220.00
Average target$283.67
High target$320.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $25,399M | $17,302M | $210M | 0.8% | |
| $25,310M | $17,259M | $5,534M | 21.9% | |
| $24,062M | $15,956M | $5,235M | 21.8% | |
| $24,564M | $16,596M | $5,116M | 20.8% |
Congress trades in JNJ
Members of Congress disclosed 11 transactions in JNJ in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/30/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 10/30/2026 filing |
| 09/08/2026 | Lloyd Doggett TX37 | Purchase | $1,001 - $15,000 | 10/5/2026 filing |
| 08/27/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 9/12/2026 filing |
| 07/30/2026 | Richard Dean Dr McCormick GA06 | Sale | $1,001 - $15,000 | 8/14/2026 filing |
| 06/29/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 7/15/2026 filing |
| 06/09/2026 | Lloyd Doggett TX37 | Purchase | $1,001 - $15,000 | 7/6/2026 filing |
| 06/02/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 7/15/2026 filing |
| 03/26/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 4/13/2026 filing |
| 03/19/2026 | Richard Dean Dr McCormick GA06 | Partial sale | $1,001 - $15,000 | 4/7/2026 filing |
| 03/19/2026 | Richard Dean Dr McCormick GA06 | Partial sale | $1,001 - $15,000 | 4/7/2026 filing |
| 03/10/2026 | Lloyd Doggett TX37 | Purchase | $1,001 - $15,000 | 4/6/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
